FDA Inspection 1181339 — District Hospital Partners LP
The FDA completed an inspection of District Hospital Partners LP on Sep 21, 2022 in Washington, DC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 21, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Washington, DC (United States)